Obesity: Drugs
Commons · Question 69602 · Tabled 21 Jul 2025 · Department of Health and Social Care · Official record
Answered 1 Sep 2025
Question
Asked by Andrew Snowden
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 21 July 2025 to Question 67568 on Obesity: Drugs, whether his Department has issued any guidance to the public on the risks of obtaining weight loss medications through on
Answer
Answered by Karin Smyth, 1 Sep 2025
The Medicines and Healthcare products Regulatory Agency (MHRA) continually monitors the safety of all medicines, including weight loss drugs such as GLP-1 receptor agonists (GLP-1 RAs).Patient safety is our top priority, and no medicine would be approved ...